Get started
Author

Michael Mu

ORCID: 0000-0003-4035-5298
Observed ORCID: 0000-0003-4035-5298
OpenAlex ID: A5070466950
Dissecting the treatment-naive ecosystem of human melanoma brain metastasis
2022 · Jana Biermann, Johannes C. Melms, et al. · Cell · 207
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity
2023 · Patricia Ho, Johannes C. Melms, et al. · Cancer Cell · 103
Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens
2024 · Zachary H. Walsh, Parin Shah, et al. · Nature Biotechnology · 39
PDF
Cutting Edge: Promoting T Cell Factor 1+ T Cell Self-Renewal to Improve Programmed Cell Death Protein 1 Blockade
2022 · Peter H Wang, Robert Washburn, et al. · The Journal of Immunology · 11
PDF
321 Genome-scale CRISPR KO screen identifies PCBP2 as a tumor-intrinsic regulator of cancer cell sensitivity to human CD4 + T cell killing
2026 · Korbinian Kropp, Jeetayu Biswas, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract 5944: Relief of chromosomal instability-induced cGAS-STING signaling sensitizes STK11-mutant non-small cell lung cancer to immune checkpoint blockade
2023 · Lindsay A. Caprio, Christy Hong, et al. · Cancer Research
Fast cell immobilization by using non-immunological method for cell based biosensor
2010 · Jihwang Park, Michael Mu, et al. · Proceedings of IEEE Sensors/Proceedings of IEEE Sensors ...
Works count: 7
Citation count: 360
H-index: 4
I10-index: 4
Year
Topic
Type